speb/financial-data huggingface dataset:
Financial ratios for LU2.DE — annual report dated 2025-06-30
Total revenue: 1645000000
Gross profit: 459900000
Operating income: -192200000
Net income: 25900000
Capital expenditures: 182900000
Operating cash flow: 126300000
Depreciation & amortization: 256700000
Net tangible assets: -391300000
Owner earnings: 99700000
Return on net tangible assets (%): -25.479171990799898
Buffett classification: The Gruesome
Stock price: 38.255319148936174
P/E ratio: 114.9136613817465
Shares outstanding: 77800000
Book value: 1134700000
P/B ratio: 2.6229521721928566
Market cap (USD): 2976263829.7872343
Debt to equity: 2.2985811227637263
Current ratio: 4.3719450101833
Quick ratio: 3.175152749490835
Interest coverage ratio: -8.657657657657658
COGS to revenue (%): 72.04255319148936
R&D to revenue (%): 18.4741641337386
SG&A to revenue (%): 21.167173252279635
Free cash flow (dilution-adjusted): -281900000
Buyback yield (%): 0
Retained earnings: -861200000
Inventory turnover: 2.520952988725803
Receivables turnover: 6.58
Capitalized R&D asset: 607948000
ROCI (R&D-adjusted, %): -4.351374547195423
Rosenberg metric: 0.6896095301125083
FCF margin (%): -17.13677811550152
Revenue growth (%): 21.027074749852854
Rule of 40 score: 3.8902966343513334
Financial ratios for LU2.DE — quarterly report dated 2025-06-30
Total revenue: 480700000
Gross profit: 159900000
Operating income: -3200000
Net income: 213300000
Capital expenditures: 6100000
Operating cash flow: 64000000
Depreciation & amortization: 61100000
Net tangible assets: -391300000
Owner earnings: 268300000
Return on net tangible assets (%): -68.56631740352671
Buffett classification: The Gruesome
Stock price: 38.255319148936174
P/E ratio: 17.590211759971833
Shares outstanding: 77800000
Book value: 1134700000
P/B ratio: 2.6229521721928566
Market cap (USD): 2976263829.7872343
Debt to equity: 2.2985811227637263
Current ratio: 4.3719450101833
Quick ratio: 3.175152749490835
Interest coverage ratio: -0.5925925925925926
COGS to revenue (%): 66.7360099854379
R&D to revenue (%): 16.53838152693988
SG&A to revenue (%): 17.391304347826086
Free cash flow (dilution-adjusted): -29900000
Buyback yield (%): 0
Retained earnings: -861200000
Inventory turnover: 0.6824079982982344
Receivables turnover: 1.9228
Capitalized R&D asset: 130353000
ROCI (R&D-adjusted, %): 0.6192728321469835
Rosenberg metric: 0.4927536231884058
FCF margin (%): -6.220095693779904
Revenue growth (%): 13.052681091251175
Rule of 40 score: 6.832585397471271
Financial ratios for LU2.DE — quarterly report dated 2025-09-30
Total revenue: 533800000
Gross profit: 181500000
Operating income: 15000000
Net income: 4200000
Capital expenditures: 76200000
Operating cash flow: 57900000
Depreciation & amortization: 62200000
Net tangible assets: -710800000
Owner earnings: -9800000
Capex to operating income (%): 508
Buffett classification: The Gruesome
Stock price: 33.564705882352946
P/E ratio: 15.059596987583964
Shares outstanding: 77800000
Book value: 780800000
P/B ratio: 3.344434064609451
Market cap (USD): 2611334117.6470594
Debt to equity: 4.201075819672131
Current ratio: 1.3665312540951382
Quick ratio: 1.018215174944306
Effective tax rate (%): 19.230769230769234
Interest coverage ratio: 2.6315789473684212
COGS to revenue (%): 65.99850131135257
R&D to revenue (%): 15.249156987635818
SG&A to revenue (%): 15.94230048707381
Free cash flow (dilution-adjusted): -60700000
Buyback yield (%): 0
Retained earnings: -857000000
Inventory turnover: 0.6627163280662152
Receivables turnover: 1.7387622149837134
Capitalized R&D asset: 159712000
ROCI (R&D-adjusted, %): 0.5379967383434383
Rosenberg metric: 0.27169811320754716
FCF margin (%): -11.371300112401649
Revenue growth (%): 11.046390680257957
Rule of 40 score: -0.3249094321436914
Financial ratios for LU2.DE — quarterly report dated 2025-12-31
Total revenue: 665500000
Gross profit: 240100000
Operating income: 63900000
Net income: 78200000
Capital expenditures: 83500000
Operating cash flow: 126700000
Depreciation & amortization: 64600000
Net tangible assets: -611000000
Owner earnings: 59300000
Return on net tangible assets (%): -9.705400981996727
Capex to operating income (%): 130.67292644757433
Buffett classification: The Gruesome
Stock price: 374.94117647058823
P/E ratio: 115.93968016459365
Shares outstanding: 77800000
Book value: 846600000
P/B ratio: 34.45596920554189
Market cap (USD): 29170423529.411766
Debt to equity: 3.924757854949209
Current ratio: 0.6060091304809427
Quick ratio: 0.4546130162437626
Effective tax rate (%): 18.963730569948186
Interest coverage ratio: 10.142857142857142
COGS to revenue (%): 63.92186326070623
R&D to revenue (%): 12.036063110443276
SG&A to revenue (%): 14.440270473328324
Free cash flow (dilution-adjusted): -2300000
Buyback yield (%): 0
Retained earnings: -778800000
Inventory turnover: 0.7457924263674615
Receivables turnover: 1.7661889596602973
Capitalized R&D asset: 160873000
ROCI (R&D-adjusted, %): 5.311872256981149
Rosenberg metric: 0.7199017199017199
FCF margin (%): -0.34560480841472574
Revenue growth (%): 24.672161858373922
Rule of 40 score: 24.326557049959195
Financial ratios for MATR.TO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.866141732283465
Shares outstanding: 61388106
Market cap (USD): 237335118.47244096
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MATR.TO — annual report dated 2022-12-31
Total revenue: 633666176.4705882
Gross profit: 189875000
Operating income: 58268382.35294117
Net income: -22050735.294117644
Capital expenditures: 26163970.588235293
Operating cash flow: 155222794.11764705
Depreciation & amortization: 42818382.35294117
Net tangible assets: 229060294.11764705
Owner earnings: -5396323.529411767
Return on net tangible assets (%): -2.3558528771643745
Capex to operating income (%): 44.90251750899111
Buffett classification: The Good
Stock price: 10.102941176470587
Shares outstanding: 61388106
Book value: 514450735.2941177
P/B ratio: 1.205558436024715
Market cap (USD): 620200423.8529412
Debt to equity: 0.38629291949009
Current ratio: 1.46277895776735
Quick ratio: 1.1032551247221536
Effective tax rate (%): -4.658489550632344
Interest coverage ratio: 3.7798712139279753
COGS to revenue (%): 70.03548444741502
R&D to revenue (%): 0.8137751135432695
SG&A to revenue (%): 15.589020940233421
Free cash flow (dilution-adjusted): 120886764.70588236
Buyback yield (%): 0.6125866026146437
Retained earnings: -118538235.29411764
Inventory turnover: 3.316897847925963
Receivables turnover: 3.1305229126178324
Capitalized R&D asset: 5156617.647058823
ROCI (R&D-adjusted, %): 7.992580161997045
FCF margin (%): 19.077357951974157
Rule of 40 score: 19.077357951974157
Financial ratios for MATR.TO — annual report dated 2023-12-31
Total revenue: 667067424.2424242
Gross profit: 211015909.0909091
Operating income: 74660606.06060606
Net income: 66075000
Capital expenditures: 43281060.6060606
Operating cash flow: 94399242.42424242
Depreciation & amortization: 27134090.909090906
Net tangible assets: 320056818.1818182
Owner earnings: 49928030.303030305
Return on net tangible assets (%): 15.59973962956388
Capex to operating income (%): 57.97041155937981
Buffett classification: The Good
Stock price: 11.484848484848484
P/E ratio: 10.670194418188698
Shares outstanding: 61388106
Book value: 552787121.2121211
P/B ratio: 1.27541519895735
Market cap (USD): 705033096.1818181
Debt to equity: 0.3185839252602857
Current ratio: 2.2800196198475526
Quick ratio: 1.8413083717316663
Effective tax rate (%): 10.401201277414716
Interest coverage ratio: 4.258761505552915
COGS to revenue (%): 68.36662960561208
R&D to revenue (%): 0.9728242908524307
SG&A to revenue (%): 15.400514917736949
Free cash flow (dilution-adjusted): 26774242.424242422
Buyback yield (%): 6.935522252435826
Retained earnings: -70334090.9090909
Inventory turnover: 4.912744009923614
Receivables turnover: 5.095801383141874
Capitalized R&D asset: 9944327.76292335
ROCI (R&D-adjusted, %): 10.07727407146134
Rosenberg metric: 4.0997627782170785
FCF margin (%): 4.013723568445786
Revenue growth (%): 5.271111037971958
Rule of 40 score: 9.284834606417744
Financial ratios for MATR.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.503703703703703
Shares outstanding: 61388106
Market cap (USD): 644802476.3555555
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MATR.TO — annual report dated 2024-12-31
Total revenue: 619102797.2027972
Gross profit: 170513986.01398602
Operating income: 41194405.5944056
Net income: -2481118.881118881
Capital expenditures: 74269930.06993008
Operating cash flow: 42338461.53846154
Depreciation & amortization: 28276223.77622378
Net tangible assets: 290753146.85314685
Owner earnings: -48474825.17482518
Return on net tangible assets (%): -16.672158392599883
Capex to operating income (%): 180.29130169077206
Buffett classification: The Gruesome
Stock price: 8.83916083916084
Shares outstanding: 61388106
Book value: 504042657.3426573
P/B ratio: 1.0765345643683728
Market cap (USD): 542619342.5454546
Debt to equity: 0.8884376807934727
Current ratio: 3.448400076956769
Quick ratio: 2.8635654726087116
Effective tax rate (%): 138.00530570995454
Interest coverage ratio: 2.0452036246224354
COGS to revenue (%): 72.45788796555358
R&D to revenue (%): 1.2170781765175638
SG&A to revenue (%): 15.10385545516465
Free cash flow (dilution-adjusted): -38779720.279720284
Buyback yield (%): 6.092050313129823
Retained earnings: -76902097.90209791
Inventory turnover: 4.489938475967831
Receivables turnover: 5.66624638386114
Capitalized R&D asset: 13584542.797888387
ROCI (R&D-adjusted, %): 4.3110712853590565
Rosenberg metric: -6.241248944844554
FCF margin (%): -6.263858030513365
Revenue growth (%): -7.19037166206993
Rule of 40 score: -13.454229692583295
Financial ratios for MATR.TO — quarterly report dated 2024-12-31
Total revenue: 145294405.5944056
Gross profit: 33055944.05594406
Operating income: -621678.3216783217
Net income: -8934965.034965035
Capital expenditures: 10490909.090909092
Operating cash flow: 31731468.531468533
Depreciation & amortization: 8337062.937062938
Owner earnings: -11088811.188811189
Buffett classification: The Gruesome
Stock price: 8.83916083916084
Shares outstanding: 61388106
Market cap (USD): 542619342.5454546
Interest coverage ratio: -0.11379928315412186
COGS to revenue (%): 77.24899047509037
R&D to revenue (%): 1.2908442467909382
SG&A to revenue (%): 16.14999205856448
Free cash flow (dilution-adjusted): 22059440.55944056
Buyback yield (%): 3.273296226083315
Inventory turnover: 2.5651020440779275
Capitalized R&D asset: 1875524.4755244756
ROCI (R&D-adjusted, %): 33.51976137211037
FCF margin (%): 15.182580822155161
Rule of 40 score: 15.182580822155161
Financial ratios for MATR.TO — quarterly report dated 2025-03-31
Total revenue: 223860139.86013988
Gross profit: 58474125.874125876
Operating income: 15627972.02797203
Net income: 36871328.67132867
Capital expenditures: 16554545.454545455
Operating cash flow: -4121678.321678322
Depreciation & amortization: 11806293.706293708
Net tangible assets: 92653846.15384616
Owner earnings: 32123076.923076928
Return on net tangible assets (%): 34.66998754669988
Capex to operating income (%): 105.92894218722033
Buffett classification: The Gruesome
Stock price: 7.160839160839162
P/E ratio: 2.9805703326632025
Shares outstanding: 61388106
Book value: 542588111.8881118
P/B ratio: 0.8101732120979355
Market cap (USD): 439590353.4545455
Debt to equity: 0.8010119847764084
Current ratio: 1.759644145969625
Quick ratio: 0.9909460493898635
Effective tax rate (%): -421.8651612202801
Interest coverage ratio: 2.323318432269467
COGS to revenue (%): 73.87917031113331
R&D to revenue (%): 0.8987254779457703
SG&A to revenue (%): 12.967012370361115
Free cash flow (dilution-adjusted): -19446153.846153848
Buyback yield (%): 1.7194966175532438
Retained earnings: -40568531.46853147
Inventory turnover: 0.9895522575408264
Receivables turnover: 1.5367997580447712
Capitalized R&D asset: 3268489.510489511
ROCI (R&D-adjusted, %): 1.6450142799936778
Rosenberg metric: 13.552572706935122
FCF margin (%): -8.68674247157316
Revenue growth (%): 54.07347512405486
Rule of 40 score: 45.3867326524817
Financial ratios for MATR.TO — quarterly report dated 2025-06-30
Total revenue: 234275182.4817518
Gross profit: 60260583.941605836
Operating income: 14124817.518248174
Net income: -5098540.145985401
Capital expenditures: 8189781.02189781
Operating cash flow: 17559854.014598537
Depreciation & amortization: 12027737.226277372
Net tangible assets: 94556204.37956204
Owner earnings: -1260583.941605839
Return on net tangible assets (%): -1.3331583579070878
Capex to operating income (%): 57.98149966410004
Buffett classification: The Good
Stock price: 8.766423357664232
P/E ratio: 23.56415997995153
Shares outstanding: 61388106
Book value: 546618978.1021897
P/B ratio: 0.9845141641250529
Market cap (USD): 538154126.3211678
Debt to equity: 0.7921249138700012
Current ratio: 1.8365614067604197
Quick ratio: 1.03198341171837
Interest coverage ratio: 1.6550632911392404
COGS to revenue (%): 74.27786276666345
R&D to revenue (%): 0.8801802110563097
SG&A to revenue (%): 13.678779400355811
Free cash flow (dilution-adjusted): 6943065.693430657
Buyback yield (%): 0.9098416467481261
Retained earnings: -47297080.2919708
Inventory turnover: 1.1441296168317592
Receivables turnover: 1.5491174639335479
Capitalized R&D asset: 4028931.9075085497
ROCI (R&D-adjusted, %): 1.4246514902181417
Rosenberg metric: 0.8879510033007798
FCF margin (%): 2.9636368734752634
Revenue growth (%): 4.6524774924731505
Rule of 40 score: 7.616114365948414
Financial ratios for MATR.TO — quarterly report dated 2025-09-30
Total revenue: 226551798.5611511
Gross profit: 53882733.81294964
Operating income: 12015107.913669067
Net income: 2056115.1079136692
Capital expenditures: 10459712.230215829
Operating cash flow: 4349640.287769784
Depreciation & amortization: 12047482.01438849
Net tangible assets: 88066906.47482015
Owner earnings: 3643884.892086331
Return on net tangible assets (%): 4.137632440998913
Capex to operating income (%): 87.05466738518652
Buffett classification: The Gruesome
Stock price: 7.712230215827339
P/E ratio: 19.018252339470965
Shares outstanding: 61388106
Book value: 551474820.1438849
P/B ratio: 0.8584965055377993
Market cap (USD): 473439205.98561156
Debt to equity: 0.8092205335594548
Current ratio: 1.8716873421033107
Quick ratio: 1.023635206422466
Effective tax rate (%): 45.880341880341874
Interest coverage ratio: 1.4158189216683623
COGS to revenue (%): 76.21615270540192
R&D to revenue (%): 0.9675872559200018
SG&A to revenue (%): 12.195029008564434
Free cash flow (dilution-adjusted): -6064028.776978417
Buyback yield (%): 0.8751209057561269
Retained earnings: -44976978.41726619
Inventory turnover: 1.1050845584680484
Receivables turnover: 1.4751677034927297
Capitalized R&D asset: 4237578.750924022
ROCI (R&D-adjusted, %): 1.1931512343476163
Rosenberg metric: -3.092975106640349
FCF margin (%): -2.6766632688381016
Revenue growth (%): -3.296714504193078
Rule of 40 score: -5.97337777303118
Financial ratios for MATR.TO — annual report dated 2025-12-31
Total revenue: 925877372.2627736
Gross profit: 232037226.27737224
Operating income: 53057664.23357664
Net income: 33978102.18978102
Capital expenditures: 45713138.68613138
Operating cash flow: 76229197.08029197
Depreciation & amortization: 49075912.40875912
Net tangible assets: 86387591.2408759
Owner earnings: 37340875.91240875
Return on net tangible assets (%): 43.22481432349536
Capex to operating income (%): 86.15746536614893
Buffett classification: The Gruesome
Stock price: 5.824817518248175
P/E ratio: 10.523675314285716
Shares outstanding: 61388106
Book value: 550226277.3722628
P/B ratio: 0.649868117801568
Market cap (USD): 357574515.2408759
Debt to equity: 0.7529072312651728
Current ratio: 1.674307656069483
Quick ratio: 0.9241384725249662
Effective tax rate (%): -176.69302165692676
Interest coverage ratio: 1.6517224141065263
COGS to revenue (%): 74.93866539687745
R&D to revenue (%): 0.9157618892949831
SG&A to revenue (%): 13.114567993112866
Free cash flow (dilution-adjusted): 30261313.868613135
Buyback yield (%): 4.751395946227555
Retained earnings: -47356934.30656934
Inventory turnover: 4.737620924935581
Receivables turnover: 7.33994155599919
Capitalized R&D asset: 15668758.690214895
ROCI (R&D-adjusted, %): 5.454122490631541
Rosenberg metric: 8.16503327857469
FCF margin (%): 3.268393285674192
Revenue growth (%): 49.55147617585185
Rule of 40 score: 52.81986946152605
Financial ratios for MATR.TO — quarterly report dated 2025-12-31
Total revenue: 228078832.1167883
Gross profit: 56072262.773722626
Operating income: 10429927.007299269
Net income: -1495620.4379562042
Capital expenditures: 9631386.861313868
Operating cash flow: 58558394.160583936
Depreciation & amortization: 12501459.854014598
Net tangible assets: 86387591.2408759
Owner earnings: 1374452.5547445249
Capex to operating income (%): 92.34376093498497
Buffett classification: The Gruesome
Stock price: 5.824817518248175
P/E ratio: 11.059022774799596
Shares outstanding: 61388106
Book value: 550226277.3722628
P/B ratio: 0.649868117801568
Market cap (USD): 357574515.2408759
Debt to equity: 0.7529072312651728
Current ratio: 1.674307656069483
Quick ratio: 0.9241384725249662
Effective tax rate (%): 77.49056055765321
Interest coverage ratio: 1.3106769400110072
COGS to revenue (%): 75.4154025372198
R&D to revenue (%): 0.9175339554770408
SG&A to revenue (%): 13.61291396238975
Free cash flow (dilution-adjusted): 49768613.13868613
Buyback yield (%): 0
Retained earnings: -47356934.30656934
Inventory turnover: 1.1744807890710274
Receivables turnover: 1.8081069351618784
Capitalized R&D asset: 4241873.024208371
ROCI (R&D-adjusted, %): 1.0627001296123926
Rosenberg metric: 0.9988333624793067
FCF margin (%): 21.820794449351613
Revenue growth (%): 0.6740328548859577
Rule of 40 score: 22.49482730423757
Financial ratios for MNC.V — annual report dated 2021-12-31
Total revenue: 0
Gross profit: -223688.97637795276
Operating income: -1734707.874015748
Net income: -2448416.5354330707
Capital expenditures: 0
Operating cash flow: -369948.031496063
Depreciation & amortization: 1348.0314960629921
Net tangible assets: 3117092.9133858266
Owner earnings: -2447068.503937008
Return on net tangible assets (%): -78.504830363846
Buffett classification: The Gruesome
Stock price: 0.14960629921259844
Shares outstanding: 59097178
Book value: 3117092.9133858266
P/B ratio: 2.8363960716476186
Market cap (USD): 8841310.09448819
Debt to equity: 0.044707515684410164
Current ratio: 0.6098607910758059
Quick ratio: 0.6098607910758059
Free cash flow (dilution-adjusted): -1241927.5590551181
Buyback yield (%): 0
Retained earnings: -35908244.09448819
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -53.19796951863239
Rule of 40 score: 0
Financial ratios for MNC.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: -209465.44117647057
Operating income: -1062377.2058823528
Net income: -4189944.8529411764
Capital expenditures: 0
Operating cash flow: -511125.7352941176
Depreciation & amortization: 2126.470588235294
Net tangible assets: -833160.294117647
Owner earnings: -4187818.382352941
Buffett classification: The Gruesome
Stock price: 0.022058823529411763
Shares outstanding: 59097178
Book value: -833160.294117647
Market cap (USD): 1303614.2205882352
Debt to equity: -0.15619478632916128
Current ratio: 0.16062556708602552
Quick ratio: 0.16062556708602552
Free cash flow (dilution-adjusted): -711525.7352941176
Buyback yield (%): 0
Retained earnings: -37721908.08823529
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MNC.V — annual report dated 2023-12-31
Total revenue: 666666.6666666666
Gross profit: 454109.0909090909
Operating income: -704481.0606060605
Net income: -1066157.5757575757
Capital expenditures: 0
Operating cash flow: -792293.1818181818
Depreciation & amortization: 0
Net tangible assets: -1414817.424242424
Owner earnings: -1066157.5757575757
Buffett classification: The Gruesome
Stock price: 0.04545454545454545
Shares outstanding: 59097178
Book value: -1414817.4242424238
Market cap (USD): 2686235.3636363633
Debt to equity: -7.268434357361671
Current ratio: 0.8989741820706156
Quick ratio: 0.8989741820706156
COGS to revenue (%): 31.883636363636363
SG&A to revenue (%): 112.11772727272728
Free cash flow (dilution-adjusted): -858292.4242424242
Buyback yield (%): 0
Retained earnings: -39931153.78787879
Receivables turnover: 5.308047724174538
Capitalized R&D asset: 0
FCF margin (%): -128.74386363636364
Rule of 40 score: -128.74386363636364
Financial ratios for MNLX.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.1496062992125984
Shares outstanding: 76412630
Market cap (USD): 87844440.78740157
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MNLX.V — annual report dated 2022-12-31
Total revenue: 21470394
Gross profit: 9374837
Operating income: -9695674
Net income: -11677230
Capital expenditures: 346774
Operating cash flow: -8361664
Depreciation & amortization: 3106166
Net tangible assets: 6934810
Owner earnings: -8917838
Return on net tangible assets (%): -128.5952751409195
Buffett classification: The Gruesome
Stock price: 0.25735294117647056
Shares outstanding: 76412630
Book value: 8776620
P/B ratio: 2.2406137070454695
Market cap (USD): 19665015.07352941
Debt to equity: 1.0597571730347217
Current ratio: 1.6344175509095646
Quick ratio: 1.374771642483121
Interest coverage ratio: -7.022125944788706
COGS to revenue (%): 56.33598060659716
SG&A to revenue (%): 71.96380280678594
Free cash flow (dilution-adjusted): -9267592
Buyback yield (%): 0.05042457360405323
Retained earnings: -109741597
Inventory turnover: 7.103242147447003
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -56.388730551965715
FCF margin (%): -43.16451761434839
Rule of 40 score: -43.16451761434839
Financial ratios for MNLX.V — annual report dated 2023-12-31
Total revenue: 24553023
Gross profit: 10121576
Operating income: -9720080
Net income: -9694592
Capital expenditures: 2597488
Operating cash flow: -2580495
Depreciation & amortization: 3481888
Net tangible assets: -1607803
Owner earnings: -8810192
Buffett classification: The Gruesome
Stock price: 0.5681818181818181
Shares outstanding: 76412630
Book value: -605896
Market cap (USD): 43416267.04545454
Debt to equity: -19.28950843048972
Current ratio: 0.7910052898485773
Quick ratio: 0.5914001155765235
Interest coverage ratio: -6.8406225478294225
COGS to revenue (%): 58.77666061730973
SG&A to revenue (%): 64.88243423223284
Free cash flow (dilution-adjusted): -5732884
Buyback yield (%): 0.02517950239377967
Retained earnings: -119436189
Inventory turnover: 10.537425650326897
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -96.72196822410972
FCF margin (%): -23.348994541323894
Revenue growth (%): 14.357580023915723
Rule of 40 score: -8.99141451740817
Financial ratios for MNLX.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.2222222222222222
Shares outstanding: 76412630
Market cap (USD): 16980584.444444444
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MNLX.V — quarterly report dated 2024-12-31
Capital expenditures: 56359
Buffett classification: The Gruesome
Stock price: 0.3496503496503497
Shares outstanding: 76412630
Market cap (USD): 26717702.7972028
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MNLX.V — annual report dated 2024-12-31
Total revenue: 26121444
Gross profit: 10981018
Operating income: -5379028
Net income: -8867299
Capital expenditures: 90240
Operating cash flow: -2143742
Depreciation & amortization: 3901135
Net tangible assets: -5963458
Owner earnings: -5056404
Buffett classification: The Gruesome
Stock price: 0.3496503496503497
Shares outstanding: 76412630
Book value: -5707002
Market cap (USD): 26717702.7972028
Debt to equity: -2.683455341350853
Current ratio: 0.8215792208557429
Quick ratio: 0.690849037474543
Interest coverage ratio: -3.2429140376028966
COGS to revenue (%): 57.9616731754952
SG&A to revenue (%): 46.261037483226424
Free cash flow (dilution-adjusted): -2916813
Buyback yield (%): 0.06247543109038387
Retained earnings: -128343247
Inventory turnover: 17.408191047796443
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -64.17323318432034
FCF margin (%): -11.166354356213997
Revenue growth (%): 6.387893661811011
Rule of 40 score: -4.778460694402986
Financial ratios for MNLX.V — quarterly report dated 2025-03-31
Total revenue: 6138301
Gross profit: 2532650
Operating income: -1815208
Net income: -2961503
Capital expenditures: 54746
Operating cash flow: -1212128
Depreciation & amortization: 826914
Net tangible assets: -1252743
Owner earnings: -2189335
Buffett classification: The Gruesome
Stock price: 0.4195804195804196
Shares outstanding: 76412630
Book value: -1023760
Market cap (USD): 32061243.356643356
Debt to equity: -12.674173634445573
Current ratio: 1.2331791573163549
Quick ratio: 1.0959259055153205
Interest coverage ratio: -3.907664818901028
COGS to revenue (%): 58.74021166443287
SG&A to revenue (%): 56.069277150143016
Free cash flow (dilution-adjusted): -1505175
Buyback yield (%): 0.07708684197014726
Retained earnings: -131316784
Inventory turnover: 3.7408451434855685
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.066386465264387
FCF margin (%): -24.52103603260902
Rule of 40 score: -24.52103603260902
Financial ratios for MNLX.V — quarterly report dated 2025-06-30
Total revenue: 7473629
Gross profit: 3183102
Operating income: -986999
Net income: -1396185
Capital expenditures: 28272
Operating cash flow: -763575
Depreciation & amortization: 781871
Net tangible assets: -2475267
Owner earnings: -642586
Buffett classification: The Gruesome
Stock price: 0.2262773722627737
Shares outstanding: 76412630
Book value: -2223019
Market cap (USD): 17290449.12408759
Debt to equity: -5.762322769171114
Current ratio: 1.1254741435149032
Quick ratio: 0.9762345589330272
Interest coverage ratio: -1.9428999435042706
COGS to revenue (%): 57.40888395717797
SG&A to revenue (%): 43.39328323629658
Free cash flow (dilution-adjusted): -997466
Buyback yield (%): 0.050276311145033524
Retained earnings: -132737881
Inventory turnover: 4.350869205004203
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.877028837931004
FCF margin (%): -13.346474651069782
Revenue growth (%): 21.754032589799685
Rule of 40 score: 8.407557938729903
Financial ratios for MNLX.V — quarterly report dated 2025-09-30
Total revenue: 7260727
Gross profit: 3104799
Operating income: -1234933
Net income: -2171472
Capital expenditures: 133479
Operating cash flow: -376605
Depreciation & amortization: 767800
Net tangible assets: -4245883
Owner earnings: -1537151
Buffett classification: The Gruesome
Stock price: 0.22302158273381295
Shares outstanding: 76412630
Book value: -3659852
Market cap (USD): 17041665.683453236
Debt to equity: -3.284920264535287
Current ratio: 0.9759329979412307
Quick ratio: 0.8155234989364324
Interest coverage ratio: -2.5005122784851137
COGS to revenue (%): 57.238483143630106
SG&A to revenue (%): 47.93986883131676
Free cash flow (dilution-adjusted): -880247
Buyback yield (%): 0.26101321799305827
Retained earnings: -134968638
Inventory turnover: 3.884293581274324
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.835470913751358
FCF margin (%): -12.123400315147505
Revenue growth (%): -2.8487097767363085
Rule of 40 score: -14.972110091883813
Financial ratios for MNLX.V — quarterly report dated 2025-12-31
Total revenue: 7030430
Gross profit: 2830583
Operating income: -1116080
Net income: -1642663
Capital expenditures: 4742
Operating cash flow: -181021
Depreciation & amortization: 599570
Net tangible assets: -5808483
Owner earnings: -1047835
Buffett classification: The Gruesome
Stock price: 0.218978102189781
Shares outstanding: 76412630
Book value: -5296186
Market cap (USD): 16732692.700729925
Debt to equity: -2.521033060394782
Current ratio: 0.7870869618532629
Quick ratio: 0.6717819074765576
Interest coverage ratio: -1.4550612555131266
COGS to revenue (%): 59.738124126120304
SG&A to revenue (%): 46.512759532489476
Free cash flow (dilution-adjusted): -317229
Buyback yield (%): 0.05477301330944898
Retained earnings: -136611301
Inventory turnover: 4.711464982443545
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.89526880095939
FCF margin (%): -4.512227559338475
Revenue growth (%): -3.1718173675996906
Rule of 40 score: -7.684044926938165
Financial ratios for MNLX.V — annual report dated 2025-12-31
Total revenue: 27903087
Gross profit: 11651134
Operating income: -5153223
Net income: -8268054
Capital expenditures: 211755
Operating cash flow: -2533329
Depreciation & amortization: 2976153
Net tangible assets: -5808483
Owner earnings: -5503656
Buffett classification: The Gruesome
Stock price: 0.218978102189781
Shares outstanding: 76412630
Book value: -5296186
Market cap (USD): 16732692.700729925
Debt to equity: -2.521033060394782
Current ratio: 0.7870869618532629
Quick ratio: 0.6717819074765576
Interest coverage ratio: -2.3073103155545747
COGS to revenue (%): 58.244283150462884
SG&A to revenue (%): 48.15089814256036
Free cash flow (dilution-adjusted): -3700117
Buyback yield (%): 0.520262946060095
Retained earnings: -136611301
Inventory turnover: 18.231737359912948
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -78.00971953290656
FCF margin (%): -13.260600879035355
Revenue growth (%): 6.820614511203899
Rule of 40 score: -6.439986367831456
Financial ratios for MPL.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.9398496240601504
Shares outstanding: 2754003240
Market cap (USD): 5342352149.774436
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for MPL.AX — annual report dated 2022-06-30
Total revenue: 4891310344.827586
Net income: 271655172.4137931
Capital expenditures: 4827586.206896552
Depreciation & amortization: 79310344.8275862
Net tangible assets: 1112620689.6551723
Owner earnings: 346137931.0344827
Return on net tangible assets (%): 31.110146903861647
Buffett classification: The Gruesome
Stock price: 1.9034482758620688
P/E ratio: 19.29690008225438
Shares outstanding: 2754003240
Book value: 1341793103.448276
P/B ratio: 3.9067891356907887
Market cap (USD): 5242102718.896551
Debt to equity: 0
Effective tax rate (%): 29.660714285714285
COGS to revenue (%): 0
SG&A to revenue (%): 10.602898877671873
Free cash flow (dilution-adjusted): 629931034.4827586
Buyback yield (%): 0.04078384474947464
Retained earnings: 1265448275.862069
Receivables turnover: 31.465838509316768
Capitalized R&D asset: 0
FCF margin (%): 12.878574248491342
Rule of 40 score: 12.878574248491342
Financial ratios for MPL.AX — annual report dated 2023-06-30
Total revenue: 4966423841.059603
Net income: 338476821.19205296
Capital expenditures: 5165562.913907285
Depreciation & amortization: 78410596.02649006
Net tangible assets: 1163112582.781457
Owner earnings: 411721854.30463576
Return on net tangible assets (%): 35.39828047600068
Buffett classification: The Gruesome
Stock price: 2.0596026490066226
P/E ratio: 16.757875320680885
Shares outstanding: 2754003240
Book value: 1380397350.9933772
P/B ratio: 4.109072191709846
Market cap (USD): 5672152368.476821
Debt to equity: 0
Effective tax rate (%): 29.707055425663597
COGS to revenue (%): 0
SG&A to revenue (%): 10.487645513581267
Free cash flow (dilution-adjusted): 94437086.09271523
Buyback yield (%): 0.05720990731167878
Retained earnings: 1305629139.0728476
Receivables turnover: 30.226924627166465
Capitalized R&D asset: 0
FCF margin (%): 1.9015108076753833
Revenue growth (%): 1.5356518179519487
Rule of 40 score: 3.437162625627332
Financial ratios for MPL.AX — annual report dated 2024-06-30
Total revenue: 5345533333.333333
Net income: 330933333.3333333
Capital expenditures: 4666666.666666667
Depreciation & amortization: 59600000
Net tangible assets: 1225800000
Owner earnings: 385866666.6666666
Return on net tangible assets (%): 31.47876216892369
Buffett classification: The Gruesome
Stock price: 2.2933333333333334
P/E ratio: 19.084953959709914
Shares outstanding: 2754003240
Book value: 1536733333.3333333
P/B ratio: 4.109917637239166
Market cap (USD): 6315847430.400001
Debt to equity: 0.09470304975922955
Effective tax rate (%): 30.251510467893777
COGS to revenue (%): 0
SG&A to revenue (%): 11.558559794470149
Free cash flow (dilution-adjusted): 540600000
Buyback yield (%): 0.07916594020199971
Retained earnings: 1378933333.3333333
Receivables turnover: 202.99493670886076
Capitalized R&D asset: 0
FCF margin (%): 10.113116246585935
Revenue growth (%): 7.633450233132861
Rule of 40 score: 17.746566479718798
Financial ratios for NTLA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 118.24
Shares outstanding: 139722277
Market cap (USD): 16520762032.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NTLA — annual report dated 2022-12-31
Total revenue: 52121000
Operating income: -458164000
Net income: -474186000
Capital expenditures: 13408000
Operating cash flow: -333287000
Depreciation & amortization: 7572000
Net tangible assets: 1235584000
Owner earnings: -480022000
Return on net tangible assets (%): -38.849807054801616
Buffett classification: The Gruesome
Stock price: 34.89
Shares outstanding: 139722277
Book value: 1235584000
P/B ratio: 3.9454300513198617
Market cap (USD): 4874910244.53
Debt to equity: 0.10578236688076245
Current ratio: 9.614844256206837
Quick ratio: 9.614844256206837
COGS to revenue (%): 0
R&D to revenue (%): 805.7769421154621
SG&A to revenue (%): 173.26221676483567
Free cash flow (dilution-adjusted): -483077000
Buyback yield (%): 0
Retained earnings: -1177187000
Receivables turnover: 13.832537154989383
Capitalized R&D asset: 419979000
ROCI (R&D-adjusted, %): -9.824878318029002
FCF margin (%): -926.8375510830568
Rule of 40 score: -926.8375510830568
Financial ratios for NTLA — annual report dated 2023-12-31
Total revenue: 36275000
Operating income: -515291000
Net income: -481192000
Capital expenditures: 13985000
Operating cash flow: -394086000
Depreciation & amortization: 8976000
Net tangible assets: 1050169000
Owner earnings: -486201000
Return on net tangible assets (%): -46.2974054652156
Buffett classification: The Gruesome
Stock price: 30.49
Shares outstanding: 139722277
Book value: 1050169000
P/B ratio: 4.056615864427535
Market cap (USD): 4260132225.73
Debt to equity: 0.1098356550231439
Current ratio: 8.665457259912506
Quick ratio: 8.665457259912506
COGS to revenue (%): 0
R&D to revenue (%): 1199.3631977946243
SG&A to revenue (%): 321.1495520330806
Free cash flow (dilution-adjusted): -542121000
Buyback yield (%): 0
Retained earnings: -1658379000
Receivables turnover: 0.9950351108185209
Capitalized R&D asset: 716454930
ROCI (R&D-adjusted, %): -19.200578556489926
FCF margin (%): -1494.475534114404
Revenue growth (%): -30.402333032750718
Rule of 40 score: -1524.8778671471546
Financial ratios for NTLA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.55
Shares outstanding: 139722277
Market cap (USD): 2871292792.35
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NTLA — annual report dated 2024-12-31
Total revenue: 57877000
Operating income: -534263000
Net income: -519021000
Capital expenditures: 5778000
Operating cash flow: -348880000
Depreciation & amortization: 10285000
Net tangible assets: 871956000
Owner earnings: -514514000
Return on net tangible assets (%): -59.00687649376803
Buffett classification: The Gruesome
Stock price: 11.66
Shares outstanding: 139722277
Book value: 871956000
P/B ratio: 1.868399035983467
Market cap (USD): 1629161749.82
Debt to equity: 0.24106491611962072
Current ratio: 5.772279907262902
Quick ratio: 5.772279907262902
COGS to revenue (%): 0
R&D to revenue (%): 805.6931077975706
SG&A to revenue (%): 217.4076057846813
Free cash flow (dilution-adjusted): -508931000
Buyback yield (%): 0
Retained earnings: -2177400000
Receivables turnover: 6.795467887753904
Capitalized R&D asset: 896400300
ROCI (R&D-adjusted, %): -25.721652465340995
FCF margin (%): -879.332031722446
Revenue growth (%): 59.55065472088214
Rule of 40 score: -819.7813770015639
Financial ratios for NTLA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.66
Shares outstanding: 139722277
Market cap (USD): 1629161749.82
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for NTLA — quarterly report dated 2025-03-31
Total revenue: 16627000
Operating income: -120807000
Net income: -114329000
Capital expenditures: 735000
Operating cash flow: -148930000
Depreciation & amortization: 2498000
Net tangible assets: 779919000
Owner earnings: -112566000
Return on net tangible assets (%): -14.43303727694799
Buffett classification: The Gruesome
Stock price: 7.11
Shares outstanding: 139722277
Book value: 779919000
P/B ratio: 1.2737545687052116
Market cap (USD): 993425389.47
Debt to equity: 0.15290434006608378
Current ratio: 4.897213858765642
Quick ratio: 4.897213858765642
COGS to revenue (%): 0
R&D to revenue (%): 652.1140313947194
SG&A to revenue (%): 174.4572081554099
Free cash flow (dilution-adjusted): -171505000
Buyback yield (%): 0
Retained earnings: -2291729000
Receivables turnover: 1.5829207920792079
Capitalized R&D asset: 108427000
ROCI (R&D-adjusted, %): -4.941189569146681
FCF margin (%): -1031.484934143261
Rule of 40 score: -1031.484934143261
Financial ratios for NTLA — quarterly report dated 2025-06-30
Total revenue: 14245000
Operating income: -109996000
Net income: -101255000
Capital expenditures: 239000
Operating cash flow: -99622000
Depreciation & amortization: 2474000
Net tangible assets: 715255000
Owner earnings: -99020000
Return on net tangible assets (%): -13.844013673445135
Buffett classification: The Gruesome
Stock price: 9.38
Shares outstanding: 139722277
Book value: 715255000
P/B ratio: 1.832346447434831
Market cap (USD): 1310594958.26
Debt to equity: 0.14343276174231567
Current ratio: 5.193195740269531
Quick ratio: 5.193195740269531
COGS to revenue (%): 0
R&D to revenue (%): 681.1863811863811
SG&A to revenue (%): 190.98631098631097
Free cash flow (dilution-adjusted): -121897000
Buyback yield (%): 0
Retained earnings: -2392984000
Receivables turnover: 1.2547344314278164
Capitalized R&D asset: 169681090
ROCI (R&D-adjusted, %): -8.370191619170637
FCF margin (%): -855.7177957177958
Revenue growth (%): -14.326096108738797
Rule of 40 score: -870.0438918265346
Financial ratios for NTLA — quarterly report dated 2025-09-30
Total revenue: 13782000
Operating income: -111477000
Net income: -101324000
Capital expenditures: 29000
Operating cash flow: -76899000
Depreciation & amortization: 4936000
Net tangible assets: 748422000
Owner earnings: -96417000
Return on net tangible assets (%): -12.882705211765554
Buffett classification: The Gruesome
Stock price: 17.27
Shares outstanding: 139722277
Book value: 748422000
P/B ratio: 3.224121850760667
Market cap (USD): 2413003723.79
Debt to equity: 0.13089674007444999
Current ratio: 6.208960160467746
Quick ratio: 6.208960160467746
COGS to revenue (%): 0
R&D to revenue (%): 687.4691626759542
SG&A to revenue (%): 221.39021912639674
Free cash flow (dilution-adjusted): -96532000
Buyback yield (%): 0
Retained earnings: -2494308000
Receivables turnover: 1.2472398190045249
Capitalized R&D asset: 195541360
ROCI (R&D-adjusted, %): -11.371897859762473
FCF margin (%): -700.4208387752141
Revenue growth (%): -3.25026325026325
Rule of 40 score: -703.6711020254774
Financial ratios for NTLA — quarterly report dated 2025-12-31
Total revenue: 23017000
Operating income: -98710000
Net income: -95786000
Capital expenditures: 126000
Operating cash flow: -69285000
Depreciation & amortization: 6015000
Net tangible assets: 671394000
Owner earnings: -89897000
Return on net tangible assets (%): -13.389604315796685
Buffett classification: The Gruesome
Stock price: 8.99
Shares outstanding: 139722277
Book value: 671394000
P/B ratio: 1.8708884354492294
Market cap (USD): 1256103270.23
Debt to equity: 0.1390077957205456
Current ratio: 5.079810172885141
Quick ratio: 5.079810172885141
COGS to revenue (%): 0
R&D to revenue (%): 385.15879567276363
SG&A to revenue (%): 143.69813616022938
Free cash flow (dilution-adjusted): -86150000
Buyback yield (%): 0
Retained earnings: -2590094000
Receivables turnover: 2.4310308407266583
Capitalized R&D asset: 184154040
ROCI (R&D-adjusted, %): -11.224667416538978
FCF margin (%): -374.28856931832996
Revenue growth (%): 67.00769119140908
Rule of 40 score: -307.28087812692087
Financial ratios for NTLA — annual report dated 2025-12-31
Total revenue: 67671000
Operating income: -440990000
Net income: -412694000
Capital expenditures: 1129000
Operating cash flow: -394736000
Depreciation & amortization: 15923000
Net tangible assets: 671394000
Owner earnings: -397900000
Return on net tangible assets (%): -59.26475363199552
Buffett classification: The Gruesome
Stock price: 8.99
Shares outstanding: 139722277
Book value: 671394000
P/B ratio: 1.8708884354492294
Market cap (USD): 1256103270.23
Debt to equity: 0.1390077957205456
Current ratio: 5.079810172885141
Quick ratio: 5.079810172885141
COGS to revenue (%): 0
R&D to revenue (%): 574.6346293094531
SG&A to revenue (%): 177.03299788683483
Free cash flow (dilution-adjusted): -476084000
Buyback yield (%): 0
Retained earnings: -2590094000
Receivables turnover: 7.147338403041825
Capitalized R&D asset: 844862140
ROCI (R&D-adjusted, %): -30.459716234218863
FCF margin (%): -703.527360316827
Revenue growth (%): 16.922093404979528
Rule of 40 score: -686.6052669118475
Financial ratios for PFAI — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 3774232.1167883207
Buffett classification: The Gruesome
Stock price: 2.37
Shares outstanding: 4041580
Book value: 3919413.8686131383
P/B ratio: 2.443871691301973
Market cap (USD): 9578544.6
Debt to equity: 0.025412149179910522
Current ratio: 5.798411624811816
Quick ratio: 5.735504258212787
Buyback yield (%): 0
Retained earnings: 8834.306569343065
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PHAR.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.002837837837837838
Shares outstanding: 414117372
Market cap (USD): 1175197.9475675677
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PHAR.L — annual report dated 2022-12-31
Total revenue: 239879518.07228917
Gross profit: 99156626.5060241
Operating income: 87108433.73493977
Net income: 29397590.361445785
Capital expenditures: 30602409.63855422
Operating cash flow: 64337349.39759036
Depreciation & amortization: 66506024.096385546
Net tangible assets: 398313253.0120482
Owner earnings: 65301204.81927711
Return on net tangible assets (%): 16.394434361766486
Capex to operating income (%): 35.131396957123094
Buffett classification: The Good
Stock price: 0.0022891566265060242
P/E ratio: 0.0322468445409836
Shares outstanding: 414117372
Book value: 398313253.0120481
P/B ratio: 0.0023799848965517247
Market cap (USD): 947979.5262650603
Debt to equity: 0.22686025408348462
Current ratio: 1.9543147208121827
Quick ratio: 1.83248730964467
Effective tax rate (%): 69.72704714640199
Interest coverage ratio: 9.904109589041095
COGS to revenue (%): 58.6639879457559
SG&A to revenue (%): 5.02260170768458
Free cash flow (dilution-adjusted): 26867469.879518073
Buyback yield (%): 368.5708189690927
Retained earnings: -18433734.93975904
Inventory turnover: 16.222222222222225
Receivables turnover: 5.996987951807229
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.071623199688595
FCF margin (%): 11.200401808136615
Rule of 40 score: 11.200401808136615
Financial ratios for PHAR.L — annual report dated 2023-12-31
Total revenue: 212531645.56962025
Gross profit: 71772151.89873417
Operating income: 59873417.721518986
Net income: -61772151.898734175
Capital expenditures: 17088607.59493671
Operating cash flow: 56835443.03797468
Depreciation & amortization: 70379746.83544303
Net tangible assets: 348354430.3797468
Owner earnings: -8481012.65822785
Return on net tangible assets (%): -2.4345930232558146
Capex to operating income (%): 28.541226215644823
Buffett classification: The Good
Stock price: 0.0022784810126582275
Shares outstanding: 414117372
Book value: 348354430.3797468
P/B ratio: 0.002708616531976744
Market cap (USD): 943558.5691139239
Debt to equity: 0.1489825581395349
Current ratio: 2.087318087318087
Quick ratio: 2.0187110187110187
Interest coverage ratio: 4.876288659793815
COGS to revenue (%): 66.22989874925551
SG&A to revenue (%): 5.360333531864205
Free cash flow (dilution-adjusted): 26329113.92405063
Buyback yield (%): 375.6315626275045
Retained earnings: -91012658.2278481
Inventory turnover: 33.696969696969695
Receivables turnover: 3.305118110236221
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.567620445096601
FCF margin (%): 12.388326384752828
Revenue growth (%): -11.40067010407594
Rule of 40 score: 0.9876562806768874
Financial ratios for PHAR.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 369625000
Buffett classification: The Gruesome
Stock price: 0.00275
Shares outstanding: 414117372
Book value: 369625000
P/B ratio: 0.0030810220439634766
Market cap (USD): 1138822.773
Debt to equity: 0.0006763611768684477
Current ratio: 4.1807909604519775
Quick ratio: 3.6553672316384183
Buyback yield (%): 0
Retained earnings: -66875000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PHAR.L — annual report dated 2024-12-31
Total revenue: 170000000
Gross profit: 60875000
Operating income: 47750000
Net income: 29500000
Capital expenditures: 23000000
Operating cash flow: 67500000
Depreciation & amortization: 59125000
Net tangible assets: 369625000
Owner earnings: 65625000
Return on net tangible assets (%): 17.754480892796753
Capex to operating income (%): 48.167539267015705
Buffett classification: The Good
Stock price: 0.00275
P/E ratio: 0.038604161796610165
Shares outstanding: 414117372
Book value: 369625000
P/B ratio: 0.0030810220439634766
Market cap (USD): 1138822.773
Debt to equity: 0.0006763611768684477
Current ratio: 4.1807909604519775
Quick ratio: 3.6553672316384183
Effective tax rate (%): 61.12026359143328
Interest coverage ratio: 11.575757575757576
COGS to revenue (%): 64.19117647058825
SG&A to revenue (%): 6.6911764705882355
Free cash flow (dilution-adjusted): 36625000
Buyback yield (%): 417.09738447599517
Retained earnings: -66875000
Inventory turnover: 9.387096774193548
Receivables turnover: 3.3580246913580245
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.326171875
FCF margin (%): 21.544117647058826
Revenue growth (%): -20.011911852293032
Rule of 40 score: 1.5322057947657939
Financial ratios for PHAR.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 367260273.9726027
Buffett classification: The Gruesome
Stock price: 0.0026027397260273972
Shares outstanding: 414117372
Book value: 399726027.39726025
P/B ratio: 0.002696446219328307
Market cap (USD): 1077839.7353424658
Debt to equity: 0.0006854009595613434
Current ratio: 5.254901960784314
Quick ratio: 4.973856209150327
Buyback yield (%): 0
Retained earnings: -79863013.69863014
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for PLXS — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 89.41
Shares outstanding: 26756421
Market cap (USD): 2392291601.61
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0